# K020911: Mid Labs Autonomous Vit Enhancer (Ave)

- Pathway: 510(k) (Traditional)
- Applicant: Medical Instrument Development Laboratories, Inc.
- Decided: Apr 29, 2002 after 40 days
- Product code: HQE (Instrument, Vitreous Aspiration And Cutting, Ac-Powered)
- Device class: 2
- Regulation: 21 CFR 886.4150
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 2 generations back to K932669 (1994). 2 ancestors in all.
9 later devices descend from it; 1 cites it directly.
0 of 12 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K992943: Vit Enhancer, Medical Instrument Development Laboratories, Inc. (1999) Summary page 1.
- K932669: Supra-Vit (TM), Medical Instrument Development Laboratories, Inc. (1994) Summary page 1.

## Most influential descendants
- K102222: Ultimate Vit Enhamcer (Uve) (2011), 8 descendants of its own
- K142877: EVA,anterior machine, EVA, combined machine, EVA combined machine with laser (DORC connector), EVA combined machine with laser SMA connector) (2015), 5 descendants of its own
- K190875: EVA, anterior machine, EVA, combined machine, EVA combined machine with laser (DORC connector), EVA combined machine with laser (SMA connector) (2019), 2 descendants of its own
- K213467: EVA NEXUS Ophthalmic Surgical System (2022), 1 descendant of its own
- K212241: Quatera 700 (2022), 1 descendant of its own

## Indications for use
The AVE is used in conjuction with ophthalmic surgical equipment (typically phacoemulsification or vitreoretinal surgical equipment) to remove vitreous and intraocular tissue.

Source page: https://510kreport.com/device/K020911
Methodology: https://510kreport.com/methodology